Pfizer and booster shots….
Representatives of Pfizer met privately with senior U.S. scientists and regulators on Monday to press their case for swift authorization of coronavirus booster vaccines, amid growing public confusion about whether they will be needed and pushback from federal health officials who say the extra doses are not necessary now.
The high-level online meeting, which lasted an hour and involved Pfizer’s chief scientific officer briefing virtually every top doctor in the federal government, came on the same day Israel started administering third doses of the Pfizer-BioNTech vaccine to heart transplant patients and others with compromised immune systems. Officials said after the meeting that more data — and possibly several more months — would be needed before regulators could determine whether booster shots were necessary.
The twin developments underscored the intensifying debate about whether booster shots are needed in the United States, at what point and for whom. Many American experts, including Dr. Anthony S. Fauci, President Biden’s chief medical adviser for the pandemic, have said there is insufficient evidence yet that boosters are necessary. Some, though, say Israel’s move may foreshadow a government decision to at least recommend them for the vulnerable….
Johnson and Johnson vaccine issues….
The Food and Drug Administration warned on Monday that Johnson & Johnson’s coronavirus vaccine can lead to an increased risk of a rare neurological condition known as Guillain–Barré syndrome, another setback for a vaccine that has largely been sidelined in the United States.
Although regulators have found that the chances of developing the condition are low, they appear to be three to five times higher among recipients of the Johnson & Johnson vaccine than among the general population in the United States, according to people familiar with the decision. The warning was attached to fact sheetsabout the vaccine for providers and patients.
Federal officials have identified 100 suspected cases of Guillain-Barré among recipients of Johnson & Johnson’s one-dose shot through a federal monitoring system that relies on patients and health care providers to report adverse effects of vaccines. Ninety-five percent of those cases were considered serious and required hospitalization, the Food and Drug Administration said. The reports are preliminary…
“Although we expected the delta variant to become the dominant strain in the United States, this rapid rise is troubling,” CDC Director Rochelle Walensky said Thursday during a White House news briefing.
In some parts of the country, she said, delta is even more widespread. For example, in parts of the Midwest and upper mountain states, including in Missouri, Nebraska, Kansas and Iowa, the CDC’s sequencing of infections suggests the new variant may account for about 80 percent of cases….
In the past week in the U.S. …
Among reported tests, the positivity rate was 3.8%.
The number of tests reported fell 28.2% from the previous week.
Since Dec. 14, more than 334,600,000 doses of a coronavirus vaccine have been administered in the U.S.
More than 159,499,000 people have completed vaccination, or about 48.04% of the population. Read more in our vaccination tracker.
Wash Post ….Link
We keep seeing CDC figures ( 58.9% adults?)) for the number vaccinated fully and just first step ….
THOSE numbers ARE different from the numbers above….
The CDC numbers are higher?
Yes ….By using Adults vs ALL American’s as their media figures…..
Only a little less than half of Americans have been fully vaccinated….
No matter what….
The Delta cases are expected to level off lower than the worst 2020 months figures simply because there ARE inoculations and some mask usage still…But there are spreading quickly in certain states….